EUSynBioS becomes a registered non-profit organization!
Dear EUSynBioS members,
It has been a great pleasure for EUSynBioS to participate and promote contents of Synthetic Biology for over 3 years now. We have started our journey as a small student organization and today we have over 400 members in all over the Europe.
To date, as EUSynBioS we have organized admirable events such as London-UK 2016, Madrid-Spain 2017, Toulouse-France 2018 and eventually this year Brno-Czechia 2019 with the participation of stakeholder, representatives of the field and greatest keynotes driving Synthetic Biology not only in Europe but globally. Together with annual meetings and conferences, our website also serves as a meeting platform for the synbio community, with exciting interviews, research and events coverage, and opinion articles on synthetic biology.
With all this experience and uninterrupted support we get from you, we thought it was time to break our shell and create a legally recognized society and continue serving synthetic biology with new missions and responsibilities that are put over our shoulders to raise this field.
Today, as the president of EUSynBioS I am pleased to inform you about a very recent development in EUSynBioS. Since July 28, 2019 we are recognized as a legal entity by the French authorities under the law for associations of July 1, 1901 and decree of August 16, 1901, and entitled as "European Synthetic Biology Society" at the physical address 128 rue la Boétie, 75008, PARIS. Our new name shows our new perspective: embrace every aspect of synthetic biology; and embrace everyone in synthetic biology. With our new legal status and new motto we are going to be in your disposal as always we have been.
What does it mean for you? In the first instance nothing changes. You continue being members of EUSynBioS. With our new legal status though we are able to create more value for our members. Some of these ways are going to be discussed in our Annual General Assembly that is taking place during our Brno symposium. So I urge you to join us to discuss and decide by vote the future of EUSynBioS
Our activities will continue non-stop such as conferences, collecting and distributing up to date news on the field, building up the network of investigators, academics, and industry representatives, and promoting synthetic biology in every related platform.
As we have done so far, the rest of the Steering Committee members and I will keep serving this community with enthusiasm and pleasure, at the best of our efforts.
Sincerely,
Huseyin Tas
President of EUSynBioS